Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Operating Expenses (2022 - 2026)

Envoy Medical's Operating Expenses history spans 5 years, with the latest figure at -$1.6 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 160.49% to -$1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.8 million, a 13.16% increase, with the full-year FY2025 number at $22.5 million, up 15.55% from a year prior.
  • Operating Expenses hit -$1.6 million in Q1 2026 for Envoy Medical, down from $6.5 million in the prior quarter.
  • Over the last five years, Operating Expenses for COCH hit a ceiling of $6.8 million in Q4 2023 and a floor of -$1.6 million in Q1 2026.
  • Historically, Operating Expenses has averaged $3.6 million across 5 years, with a median of $4.5 million in 2023.
  • Biggest five-year swings in Operating Expenses: skyrocketed 404.02% in 2023 and later crashed 160.49% in 2026.
  • Tracing COCH's Operating Expenses over 5 years: stood at $2.9 million in 2022, then skyrocketed by 133.01% to $6.8 million in 2023, then plummeted by 32.66% to $4.6 million in 2024, then surged by 40.71% to $6.5 million in 2025, then tumbled by 124.8% to -$1.6 million in 2026.
  • Business Quant data shows Operating Expenses for COCH at -$1.6 million in Q1 2026, $6.5 million in Q4 2025, and $5.8 million in Q3 2025.